Adicon Holdings Valuation Multiples
Adicon Holdings is valued at $401M as of November 2026, a 1.3x revenue multiple. In the last fiscal year, Adicon Holdings revenue was $396M and Adicon Holdings EBITDA was $41M.
Adicon Holdings Overview
About Adicon Holdings
Founded in 2004 and listing on the Hong Kong Exchange in 2023, Adicon is one of the independent clinical laboratories in China. In October 2018, private equity Carlyle Group completed its investment in Adicon and has since been the large single shareholder. Following Carlyle’s investment, Adicon quickly stepped up its footprint. It has a testing portfolio of over 4,000 medical diagnostic tests with 34 self-operated laboratories in 2024, compared with 1,800 items and 21 labs in 2018. Currently, esoteric tests account for nearly 60% of its testing portfolio. Esoteric tests require more specialized technologies and/or equipment.
Founded
2008
HQ
Employees
5.4K
Website
Financials (Last FY)
EV
$529M
Valuation Multiples
Start free trial
Adicon Holdings Financials
Adicon Holdings reported last fiscal year revenue of $396M and EBITDA of $41M.
In the same fiscal year, Adicon Holdings generated $143M in gross profit, $41M in EBITDA, and $3M in net income.
Adicon Holdings P&L
In the most recent fiscal year, Adicon Holdings reported revenue of $396M and EBITDA of $41M.
Adicon Holdings is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 10%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Adicon Holdings Stock Performance
Adicon Holdings has current market cap of $401M, and enterprise value of $529M.
Market Cap Evolution
Adicon Holdings' stock price is $0.56.
Adicon Holdings share price decreased by 2.1% in the last 30 days.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $529M | $401M | 0.0% | -2.1% | - | - | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAdicon Holdings Valuation Multiples
Adicon Holdings trades at 1.3x EV/Revenue multiple, and 13.0x EV/EBITDA.
Adicon Holdings Financial Valuation Multiples
As of November 9, 2026, Adicon Holdings has market cap of $401M and EV of $529M.
Adicon Holdings has a P/E ratio of 145.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Adicon Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Adicon Holdings Margins & Growth Rates
In the most recent fiscal year, Adicon Holdings reported gross margin of 36%, EBITDA margin of 10%, and net margin of 1%.
Adicon Holdings Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Adicon Holdings Operational KPIs
Adicon Holdings' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Adicon Holdings Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Adicon Holdings competitors and their valuation data. Start Free Trial | ||||||
Adicon Holdings VC Funding History
Before going public, Adicon Holdings raised funding across 1 round.
Last private valuation of Adicon Holdings was $440M, after raising a round in October 2018 from Carlyle Group.
Adicon Holdings Funding Rounds
Acquisitions by Adicon Holdings
Adicon Holdings has acquired 1 company to date.
Last acquisition by Adicon Holdings was on November 13th 2025. Adicon Holdings acquired Crown Bioscience for $204M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Adicon Holdings
| Description | Crown Bioscience is a precision medicine company offering translational platforms including over 4,000 patient-derived xenograft models and HuGEMM humanized mouse strains for oncology research. The San Diego-headquartered firm operates research facilities in Taicang, Beijing, Altringham, and Taipei, supporting biopharmaceutical clients worldwide in accelerating drug discovery for cancer, cardiovascular, and metabolic diseases. Crown Bioscience provides in vitro assays, in vivo efficacy studies, and biomarker services to more than 800 partners globally. |
| HQ Country |  |
| HQ City | San Jose, CA |
| Deal Date | 13 Nov 2025 |
| Valuation | $204M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Adicon Holdings acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Adicon Holdings
| When was Adicon Holdings founded? | Adicon Holdings was founded in 2008. |
| Where is Adicon Holdings headquartered? | Adicon Holdings is headquartered in China. |
| How many employees does Adicon Holdings have? | As of today, Adicon Holdings has over 5K employees. |
| Is Adicon Holdings publicly listed? | Yes, Adicon Holdings is a public company listed on HKEX. |
| What is the stock symbol of Adicon Holdings? | Adicon Holdings trades under 09860 ticker. |
| When did Adicon Holdings go public? | Adicon Holdings went public in 2023. |
| Who are competitors of Adicon Holdings? | Adicon Holdings main competitors include |
| What is the current market cap of Adicon Holdings? | Adicon Holdings' current market cap is $401M. |
| What is the current revenue of Adicon Holdings? | Adicon Holdings' last fiscal year revenue is $396M. |
| What is the current EV/Revenue multiple of Adicon Holdings? | Current revenue multiple of Adicon Holdings is 1.3x. |
| Is Adicon Holdings profitable? | No, Adicon Holdings is not profitable. |
| How many companies Adicon Holdings has acquired to date? | As of November 2026, Adicon Holdings has acquired 1 company. |
| What was the largest acquisition by Adicon Holdings? | $204M acquisition of Crown Bioscience on 13th November 2025 was the largest M&A Adicon Holdings has done to date. |
| What companies Adicon Holdings acquired? | Adicon Holdings acquired Crown Bioscience. |
| In how many companies Adicon Holdings has invested to date? | Adicon Holdings hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Adicon Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.